Skip to content

A prospective cohort study on TCM syndrome evolution and etiology and pathogenesis of cerebral infarction

A prospective cohort study on TCM syndrome evolution and etiology and pathogenesis of cerebral infarction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066440
Enrollment
Unknown
Registered
2022-12-06
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral infarction

Interventions

Sponsors

The Second Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of Western medicine for acute ischemic stroke; (2) Those who meet the diagnosis of acute stage of the meridian in traditional Chinese medicine (without coma); (3) Aged >= 35 years old and <= 80 years old; (4) The patient himself or his legal guardian signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) Western medicine diagnosed as TIA, hemorrhagic stroke and mixed stroke; (2) Patients with severe hypertension, severe cardiopulmonary insufficiency, severe arrhythmia, complicated symptoms of liver, kidney, hematopoietic system or other serious primary diseases; (3) Those with mental illness or unable to correctly understand and accurately express TCM syndromes and their family members cannot express on their behalf, resulting in inaccurate medical records; (4) Pregnant or lactating women; (5) Those whose medical history records are not detailed and cannot be extracted.

Design outcomes

Primary

MeasureTime frame
Scores of TCM syndrom;Basic Information;NIHSS score;

Countries

China

Contacts

Public ContactXu Bin

The Second Affiliated Hospital of Zhejiang Chinese Medical University

whtong@126.com+86 13858088545

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026